Breaks Categories: News

TuesdayApr 22, 2025 3:20 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Launches Edits App to Empower Creators 

Meta Platforms (NASDAQ: META) has officially launched Edits, a standalone mobile video creation app designed to help creators produce high-quality content, including Instagram Reels, directly from their phones. The free app offers long-form capture, clip-level editing, real-time insights, and seamless integration with Instagram and Facebook.   As of 1:14 p.m. EDT on April 22, 2025, Meta's stock is trading at $505.66, up $21.00 (4.33%) from the previous close.   To view the full article, visit https://nnw.fm/j3gDg  About Meta Platforms Inc.  Meta Platforms Inc. is a leading technology company that builds innovative products and services to connect people and communities. The company's offerings…

Continue Reading

TuesdayApr 22, 2025 3:12 pm

NetworkNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Rises as Market Rebounds and Analysts Maintain Optimism 

NVIDIA (NASDAQ: NVDA) shares are climbing today, buoyed by a broader market recovery and continued analyst support. After a sharp decline on Monday, prompted by President Donald Trump's criticism of Federal Reserve Chair Jerome Powell and concerns over interest rate policies, the market is rebounding. Nvidia, having dropped approximately 4.8% in the previous session due to reports of potential delays in upcoming chip releases, is now benefiting from renewed investor confidence. Analysts at Barclays and Bank of America have both lowered their price targets for Nvidia but maintained buy-equivalent ratings, citing the company's strong earnings potential despite geopolitical challenges. ​  …

Continue Reading

TuesdayApr 22, 2025 3:10 pm

NetworkNewsBreaks – BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB), SpayVac-for-Wildlife Inc. Expand License Agreement

BioVaxys (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB) and SpayVac-for-Wildlife announced an expansion of the fields of use in the current license agreement to include commercial aquaculture and the farm-raised fish market. With this expansion, SpayVac’s markets now include its no-booster fertility-control vaccines for aquaculture and overabundant feral/wild/invasive and select production and companion animals, which significantly increases its global revenue potential. “This presents a substantial addressable market for SpayVac’s contraceptive vaccines, which are being developed as an alternative to triploidy—a form of genetic manipulation commonly used in aquaculture to induce sterility,” said SpayVac-for-Wildlife CEO Thomas D’Orazio. “With only a single dose…

Continue Reading

TuesdayApr 22, 2025 3:02 pm

NetworkNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Downgraded by Raymond James Amid Tariff Concerns and Earnings Pressure 

Amazon.com (NASDAQ: AMZN) has been downgraded by Raymond James from "strong buy" to "outperform," with the price target reduced nearly 30% to $195. The downgrade reflects concerns over rising U.S.-China trade tensions and Amazon's $15 billion investment in rural U.S. logistics infrastructure, which analysts believe may pressure earnings before interest and taxes (EBIT). Approximately 30% of Amazon's gross merchandise value is linked to Chinese products, making the company vulnerable to potential tariff impacts. Despite these challenges, Bank of America Securities maintains a "buy" rating with a $225 price target, acknowledging the risks but remaining optimistic about Amazon's long-term prospects.  As…

Continue Reading

TuesdayApr 22, 2025 1:50 pm

NetworkNewsBreaks – Asure Software Inc. (NASDAQ: ASUR) Secures $60M Credit Facility

Asure Software (NASDAQ: ASUR), a provider of integrated software solutions, has announced its entry into a significant financial agreement, securing a credit facility of up to $60 million. Established with MidCap Financial, the agreement provides the company with an immediate $20 million in funding, with the remaining $40 million available until March 31, 2027. Roth Capital Partners acted as exclusive financial advisor for the offering. For more information, visit https://nnw.fm/ycGdE About Asure Software Inc. Asure provides cloud-based Human Capital Management (“HCM”) software solutions that assist organizations of all sizes in streamlining their HCM processes. Asure's suite of HCM solutions includes…

Continue Reading

TuesdayApr 22, 2025 1:40 pm

NetworkNewsBreaks – Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B) Reaffirms Confidence in VeriSign (NASDAQ: VRSN) Despite Market Skepticism

Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) continues to hold VeriSign Inc. (NASDAQ: VRSN) as a core position, citing the company’s durable competitive moat and mission-critical role in global internet infrastructure. VeriSign’s exclusive control over the .com and .net registries generates stable, recurring cash flows—hallmarks of the type of business Berkshire favors. While some analysts have flagged the stock’s premium valuation and modest growth outlook, Berkshire remains focused on VeriSign’s long-term ability to protect and grow capital without the need for constant reinvention. As of early afternoon trading on April 22, 2025, VeriSign shares are trading at $241.34, down $5.33 or…

Continue Reading

TuesdayApr 22, 2025 1:20 pm

NetworkNewsBreaks – Newton Golf Company Inc.’s (NASDAQ: NWTG) Tech-Driven Strategy Featured in GotStocks Podcast

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design, was featured in the GotStocks Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Greg Campbell, NWTG’s CEO, joined the program to discuss Newton Golf’s mission, vision and recent milestones. “Newton Golf Company is a golf equipment company, but I like to think of it as a technology company. At our core, we have truly technically differentiated products. In fact, that’s why we rebranded to Newton Golf Company—after Sir Isaac Newton, who is known…

Continue Reading

TuesdayApr 22, 2025 10:16 am

NetworkNewsBreaks – Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) Partners with Crypto.com, Yorkville to Launch America-First ETFs 

Trump Media and Technology Group (Nasdaq, NYSE Texas: DJT)  has signed a binding agreement with Crypto.com and Yorkville America Digital to launch a series of exchange-traded funds and products through its Truth.Fi brand. The ETFs will include digital assets and U.S.-focused securities spanning sectors like energy. Subject to regulatory approval, the offerings will launch later this year with global distribution via Crypto.com’s Foris Capital US LLC. TMTG plans to invest up to $250 million into the initiative from its cash reserves, with custody by Charles Schwab.  To view the full press release, visit https://nnw.fm/SkY3b  About Trump Media and Technology Group…

Continue Reading

TuesdayApr 22, 2025 10:04 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Pursues Government Support as Montauban Project Nears Production

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced ongoing discussions with both the Quebec and Canadian governments to secure non-dilutive funding as it advances its fully permitted Montauban Project toward near-term gold and silver production. With construction of a 500-tonne pilot plant and 1,000-tonne commercial facility underway, ESGold aims to create up to 30 direct jobs, prioritize local contractors, and lead in sustainable mining innovation through clean technology and proprietary equipment.  To view the full press release, visit https://nnw.fm/yMotM  About ESGold Corp.  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully permitted, pre-production resource company at the forefront of clean mining and…

Continue Reading

TuesdayApr 22, 2025 9:30 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Host Investor Webinar Highlighting Cancer Immunotherapy Pipeline

Calidi Biotherapeutics (NYSE American: CLDI) will host a live investor webinar on April 24, 2025, at 4:15 p.m. ET, featuring its new Chief Medical Officer, Dr. Guy Travis Clifton. The event will spotlight Calidi’s stem cell-based delivery platforms for oncolytic virus therapies, including the FDA-cleared CLD-201, which is advancing toward trials for solid tumors. Additional program updates will include CLD-400 for metastatic and lung cancer and CLD-101 for high-grade gliomas. A live Q&A will follow the presentation. To view the full press release, visit: https://nnw.fm/Crc5I About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to…

Continue Reading